Milestone
4.1.a
Preferred product characteristics
In progress
Develop a set of preferred product characteristics (PPCs) for broadly protective and universal influenza vaccines, in collaboration with the WHO’s efforts to revise its 2017 guidance on PPCs for next-generation influenza vaccines.
Progress Highlights
Bresee 2023: WHO is updating the 2017 PPCs for Next-Generation Influenza Vaccines to guide R&D efforts towards improved influenza vaccines suitable for use in low-resource settings (publication expected in 2025).